Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

Clinical trial NCT01879319 · COMPLETED

Trial details

NCT number: NCT01879319
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hypercholesterolemia Mixed Dyslipidemia

Start date: 2013-07-11
Primary completion: 2013-11-15
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.